Casdin Capital, LLC EDIT — EDITAS MEDICINE INC

Ownership history in Casdin Capital, LLC  ·  15 quarters on record

AI Ownership Summary

Casdin Capital, LLC reported EDITAS MEDICINE INC (EDIT) in 15 quarterly 13F filings from 2026 Q2 through 2026 Q2. Peak portfolio weight reached 0.07% in 2026 Q2. The latest visible filing shows EDIT at 0.07% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this EDIT ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Casdin Capital, LLC's position in EDITAS MEDICINE INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

EDIT was reported at 0.07% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.07% in 2026 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2026 Q2 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

EDIT stock page Casdin Capital, LLC fund profile Casdin Capital, LLC full holdings
How Casdin Capital, LLC held EDIT — position size vs. price
% of Fund (quarterly)    EDIT price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 1 quarter  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 ADDED — — — 445,000 +30,000 +7.2% 0.07% $1.4M 2026-08-14 $2.82
14 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding EDIT

As of 2026 Q2 — sorted by position size

GordonMD Global Investments LP 4.9% Commodore Capital LP 3Y 1.72% ADAR1 Capital Management, LLC 1.32% Opaleye Management Inc. 3Y 7Y 1.13% Vivo Capital, LLC 3Y 7Y 1.05% TCG Crossover Management, LLC 3Y 0.87% Seven Fleet Capital Management LP 0.71% Green Alpha Advisors, LLC 3Y 0.34% Paradigm Biocapital Advisors LP 3Y 0.34% Logos Global Management LP 3Y 0.31%

FAQ About Casdin Capital, LLC and EDIT

These are the practical questions this page is built to answer before you even open the full history table.

How long has Casdin Capital, LLC reported owning EDIT?

Casdin Capital, LLC reported EDIT across 1 quarterly 13F filings, from 2026 Q2 through 2026 Q2.

What was the largest reported EDIT position in Casdin Capital, LLC's portfolio?

The largest reported portfolio weight for EDIT was 0.07% in 2026 Q2.

What is the latest reported EDIT position on this page?

The most recent filing on this page is 2026 Q2, when Casdin Capital, LLC reported 445,000 shares, equal to 0.07% of portfolio, with an estimated market value of $1.4M.

What does the chart on this EDIT ownership page compare?

The chart compares Casdin Capital, LLC's quarterly EDIT portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Casdin Capital, LLC time their EDIT position?

Based on 13F filing dates vs. subsequent EDIT price moves, Casdin Capital, LLC correctly timed 3 out of 7 reported position changes (43%). The annualised alpha on EDIT relative to SPY over the holding period was -19.9%.

← Back to Casdin Capital, LLC Holdings